Search

Anti-obesity medications, including semaglutide (Ozempic/Wegovy), can effectively help patients manage weight regain after bariatric surgery, a study led by UT Southwestern Medical Center researchers shows.

A novel, minimally invasive surgical technique for correcting blepharoptosis – often called “droopy eyelid” – is more efficient and produces better results than the traditional method that uses sutures, according to a UT Southwestern Medical Center study.

Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Medical Center researchers report in a new study.

Overdose deaths from opioids, including prescription painkillers and synthetics like fentanyl, continue to rise. According to the Centers for Disease Control and Prevention, an estimated 187 people in the U.S. die every day of opioid overdoses, most involving illicit and dangerous versions of fentanyl.

Women who take oral contraceptives may be significantly less likely to experience certain musculoskeletal injuries than women who do not take the drugs or men, according to a study by UT Southwestern Medical Center.

Heart failure patients may one day be able to restore cardiac function with medications that revive the body’s ability to regenerate heart muscle, a novel study at UT Southwestern Medical Center suggests.

Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

Two hard-to-match transplant patients 250 miles apart are starting 2024 on a new path to healthy lives. That’s because UT Southwestern Medical Center’s Solid Organ Transplant Program and University Health Transplant Institute in San Antonio searched beyond their own institutional networks to identify compatible living kidney donors for their failing patients.

A gene therapy developed by researchers at UT Southwestern Medical Center for a rare disease called giant axonal neuropathy (GAN) was well tolerated in pediatric patients and showed clear benefits, a new study reports.